Clinical Trial Update: Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluate the safety and efficacy of oxcarbazepine as monotherapy in adults with partial seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: Novartis | Conditions: Epilepsy, Partial Seizures | Phase 4 | Status: COMPLETED